Search Results

< Back Podcast Thursday Jan 13, 2022 Compliance and Marketing Claims Canna Advocate Podcast A warning letter is a FTC notice to crack down on false claims. Why is this a problem? It can threaten your business! A warning letter requires legal resources to answer, which takes away your mental bandwidth. Warning letters are a public notice and can scare away investors. Also, warning letters are used for future class action lawsuits. Avoid the warning letter before it's an issue. Influencer marketing is an enforcement trend to pay attention to. People can make reviews and say whatever they want. But the seller must be careful to use reviews in a marketing campaign. Other terms to take seriously include, THC free or pesticide free. They maybe troublesome terms unless it's 100% true. Dietary supplement marketing examples that work include gaiaherbs.com . Future of Cannabis Marketing Future of the hemp and cannabis industry will be technologies that promote bio-availability products for efficiently absorbing cannabinoids and other nutraceuticals. Listen Previous Next

< Back Symposium Friday Jun 9, 2023 16th International Herb Symposium at Wheaton College in Norton, Massachusetts, on June 9-11, 2023 International Herb Symposium Asa teaches various GMP and marketing compliance classes at this three-day event. Learn More Previous Next

In his quarterly update, consultant Asa Waldstein identifies trends in FDA warning letters impacting manufacturers and marketers of dietary supplements. < Back Q1 FDA warning letter roundup with Asa Waldstein Asa Waldstein Guest Article In his quarterly update, consultant Asa Waldstein identifies trends in FDA warning letters impacting manufacturers and marketers of dietary supplements. Read More Previous Next

< Back Podcast Monday Apr 17, 2023 The Hoban Minute - Episode 170 with Asa Waldstein of Supplement Advisory Group The Hoban Minute In this short, special episode straight from the NOCO 9 trade show in Colorado Springs, Xavier interviews Asa Waldstein, founder of Apex Compliance and principal at Supplement Advisory Group. Xavier gets a first look at Asa’s new compliance tool, Apex, and the two discuss the dire need for marketing claim reviews in the hemp cannabinoid product space and how Apex Compliance is a tool designed specifically to help brands, marketers, consultants, and more navigate the ever-changing regulations around marketing their products. Listen Previous Next

Asa and other industry leaders interviewed. < Back FDA Objects to CBD Being Sold as a Dietary Supplement; Industry Leaders Speak Out Steven Hoffman Interview Asa and other industry leaders interviewed. Read More Previous Next

Asa and other industry experts interviewed < Back Ten experts reflect on state of U.S. hemp industry Interview Asa and other industry experts interviewed Read More Previous Next

< Back Online Tuesday Dec 10, 2024 Navigating GLP-1 Regulatory Compliance: Marketing Best Practices in the Supplement Industry Naturally Informed Active Aging Event This presentation will delve into the current marketing landscape surrounding GLP-1 in the U.S. supplement industry. Asa will look at biomarker enforcement, such as LDLs, to gain insights into marketing best practices, focusing on compliant strategies and pitfalls to avoid when promoting GLP-1-related products. Learn More and Register Previous Next

Asa Waldstein & other leaders interviewed < Back USDA Final Hemp Rule draws mixed reactions from industry stakeholders Danielle Masterson Interview Asa Waldstein & other leaders interviewed Read More Previous Next

Suprimo Imports still lists for sale products targeted by FDA in a warning letter, raising the question whether the company will face any legal or criminal action. < Back FDA targets AK Forte distributor for selling drugs, not supplements Kelly Teal Interview Suprimo Imports still lists for sale products targeted by FDA in a warning letter, raising the question whether the company will face any legal or criminal action. Read More Previous Next

< Back Symposium Wednesday Nov 11, 2020 Symposium Keynote: Consumer Demand & the CBD Market: Intersections & Insights Michigan State University: Center for Research on Ingredient Safety Asa Waldstein Supplement Advisory Group: Consumer Demand & the CBD Marketplace, Intersections & Insights Patrick C. McCarthy ValidCare : Answering FDA’s Call for CBD Safety Data Jinpeng Li: Introduction to cannabinoids and the new wonder drug/consumer product: CBD Barbara Kaplan: Inhibition of Peripheral Immune Function and Neuroinflammation by CBD in EAE Brad Lampe: Derivation of an acceptable daily intake of orally-consumed cannabidiol (CBD) in adult consumers: challenges and limitations and more.. Watch Previous Next

< Back Webinar Tuesday Sep 24, 2024 Technology solutions for marketing and manufacturing supplements in the US FoodChain ID Asa Waldstein of Apex Compliance and Jérôme Le Bloch and Amélie Denis of FoodChain ID partner in this educational webinar. They review technology solutions for ingredient suitability, marketing compliance, and more. Ingredient Suitability & Claims: FoodChain ID’s experts will guide you through determining ingredient suitability and navigating claims regulations in the U.S. Regulatory Compliance: Discover how FoodChain ID’s Supplements R&D Insight tool offers comprehensive regulatory data and scientific analysis to simplify compliance. Content & Enforcement Trends: Apex will demonstrate how their Compliance tools help avoid costly FDA warning letters and litigation through efficient content review and risk management. Learn More and Register Previous Next

< Back Webinar Tuesday Dec 10, 2019 Supplement cGMP Basics for Hemp-CBD Companies American Herbal Products Association This webinar provides an overview of dietary supplement current good manufacturing (cGMP) requirements for hemp-CBD products. Legal and industry experts provide strategies and resources to comply and document compliance with these federal manufacturing requirements designed to ensure product quality and safety. Topics Overview of cGMP requirements Strategies to comply and document compliance cGMP resources for hemp-CBD companies Preparing for and conducting an FDA cGMP inspection Presenters Tara Lin Couch , Ph.D., Sr. Dir. of Dietary Supplement and Tobacco Services, EAS Consulting Ricardo Carvajal , Esq., Director, Hyman, Phelps & McNamara PC Asa Waldstein Watch Previous Next